Across TCGA pan-cancer cohorts, RPL21P67 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated RPL21P67 data layer.

The strongest signal is observed in brain lower grade glioma (LGG), where higher RPL21P67 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RPL21P67 expression acts as an unfavorable survival marker, although some lineages such as LGG and SKCM show a favorable association.

LGG, UVM, and BLCA are the cancer types where RPL21P67 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LGG	DFS	Median	All	0.454	0.335	<.001	40	view →
UVM	DFS	Tertile	III,IV	0.391	0.786	.003	40	view →
BLCA	OS	Quartile	IV	0.276	0.516	.002	31	view →
SKCM	OS	Quartile	III,IV	0.593	0.342	.002	23	view →
OV	DFS	Median	III,IV	0.333	0.404	.021	18	view →
THYM	DFS	Median	All	0.962	0.848	.009	17	view →
PRAD	DFS	Median	All	0.885	0.678	.003	14	view →
STAD	OS	Tertile	II,III,IV	0.588	0.811	.026	11	view →
KIRP	DFS	Tertile	II,III,IV	1.000	0.602	.032	10	view →
READ	OS	Median	All	0.970	0.831	.023	8	view →
MESO	OS	Tertile	IV	0.773	0.328	.049	4	view →
PAAD	DFS	Median	III,IV	0.893	0.470	.024	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

Exploration

Same gene, other analysis: RPL21P67 tumor-vs-normal RNA expression · all RPL21P67 data types